Business Context and Reporting Period
This Form 8-K is filed by AIT Therapeutics, Inc. (not Beyond Air, Inc.) on February 14, 2019, reporting events occurring on February 11 and February 13, 2019. The filing covers the announcement of financial results for the quarter ended December 31, 2018, and changes to the Board of Directors.
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing the financial results for the quarter ended December 31, 2018. However, the text of this Form 8-K does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that the information in Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Material Changes
- Board Composition: Ari Raved resigned from the Board of Directors effective February 11, 2019. The resignation was not due to any disagreement with the Company regarding operations, policies, or practices.
- Director Appointment: Robert F. Carey was appointed to the Board of Directors effective February 11, 2019, to fill the vacancy created by Mr. Raved's resignation.
Guidance, Outlook, and Risks
The filing does not contain specific guidance, outlook, or management commentary regarding future financial performance, as the detailed results are contained in the attached press release. No specific risks or contingencies are detailed in the text of this report, other than the standard disclosure regarding the non-filing status of the financial results.
Investor Verification Checklist
- Verify the specific financial figures for the quarter ended December 31, 2018, by reviewing Exhibit 99.1 (Press Release) attached to this filing, as they are not listed in the main text.
- Confirm the background and potential conflicts of interest for the new director, Robert F. Carey, noting his current role at Horizon Pharma plc and board seat at Sangamo Therapeutics, Inc.
- Review the full text of the press release to understand the context of the financial results, as the 8-K text explicitly disclaims liability for the financial data presented.